Trials / Completed
CompletedNCT01680263
Kinesiotaping in Treatment of Pes Anserinus Tendino-bursitis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Shiraz University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to determine the effects of kinesiotaping in comparison to NSAIDs and physical therapy in treatment of pes anserinus tendino-bursitis.
Detailed description
The treatment of pes anserinus tendino-bursitis includes refraining from aggravating activities, local modalities such as heat, ice, ultrasound (US), iontophoresis, phonophoresis, electrical stimulation (ES), nonsteroidal anti-inflammatory drugs (NSAIDs) and injections with either corticosteroids or local anesthetics. Another treatment that seems to have a significant effect on the improvement of the disease is kinesiotaping. Kinesiotaping is a cotton strip with an acrylic adhesive that is used for treating athletic injuries and a variety of physical conditions. The therapeutic effects of the tape is to relax the overused muscles and in rehabilitation to facilitate the underused muscles. Advocates claim that the wave pattern found on the kinesiotaping has a lifting effect on the skin which can diminish swelling and inflammation via improving circulation and reduce pain by removing pressure from pain receptors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Kinesiotaping | Use of kinesiotaping on the painful area in the form of "space correction". Kinesiotaping was repeated for 3 weeks with 1week interval |
| PROCEDURE | NSAIDs/Physical therapy | Use of non-steroidal anti-inflammatory drugs and 10 sessions of daily physical therapy. |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2012-06-01
- Completion
- 2012-07-01
- First posted
- 2012-09-07
- Last updated
- 2012-09-07
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT01680263. Inclusion in this directory is not an endorsement.